See more : Red Trail Energy, LLC (REGX) Income Statement Analysis – Financial Results
Complete financial analysis of Panaxia Labs Israel Ltd (PNAX.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Panaxia Labs Israel Ltd, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- IL&FS Investment Managers Limited (IVC.NS) Income Statement Analysis – Financial Results
- Angling Direct PLC (ANG.L) Income Statement Analysis – Financial Results
- Iterum Therapeutics plc (ITRM) Income Statement Analysis – Financial Results
- NR21 Société Anonyme (NR21.PA) Income Statement Analysis – Financial Results
- Aristocrat Group Corp. (ASCC) Income Statement Analysis – Financial Results
Panaxia Labs Israel Ltd (PNAX.TA)
About Panaxia Labs Israel Ltd
Panaxia Labs Israel Ltd provides pharmaceutical solutions for patients and physicians in Israel and internationally. It offers pharma-grade smokeless cannabis products, such as oral tablets, orodispersible tablets, sublingual tablets, oral oils, sublingual drops, solution for inhalation, pastilles, topicals, suppositories, and cannabis extracts in ethanol under the NAXIVA PANAXOL, NAXIVA-PANAXOL-ONKO, PANAXIR SENSE, PANAXIR, Axiban, Tikva, Ultra Health, and Salus brands. The company was incorporated in 2005 and is based in Lod, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19.59M | 39.42M | 83.60M | 60.75M | 16.69M | 0.00 | 231.00K | 0.00 |
| Cost of Revenue | 25.41M | 60.25M | 83.06M | 56.50M | 18.59M | 0.00 | 1.77M | 0.00 |
| Gross Profit | -5.82M | -20.84M | 535.00K | 4.25M | -1.90M | 0.00 | -1.54M | 0.00 |
| Gross Profit Ratio | -29.72% | -52.86% | 0.64% | 7.00% | -11.40% | 0.00% | -665.80% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.62M | 8.17M | 7.93M | 8.28M | 1.02M | 917.00K | 840.00K | 301.00K |
| Selling & Marketing | 3.59M | 231.00K | 11.17M | 6.20M | 24.01M | 0.00 | 713.00K | 0.00 |
| SG&A | 10.20M | 8.40M | 19.10M | 14.47M | 25.03M | 917.00K | 713.00K | 301.00K |
| Other Expenses | 8.30M | -4.20M | 14.76M | 0.00 | -42.77M | 12.07M | -5.00K | 22.00K |
| Operating Expenses | 13.10M | 16.94M | 35.45M | 39.60M | 27.10M | 1.97M | 713.00K | 1.09M |
| Cost & Expenses | 38.50M | 77.19M | 118.51M | 96.10M | 45.69M | 1.97M | 2.48M | 1.09M |
| Interest Income | 322.00K | 597.00K | 874.00K | 0.00 | 0.00 | 62.00K | 65.00K | 36.00K |
| Interest Expense | 3.11M | 2.23M | 1.78M | 553.00K | 854.00K | 242.00K | 0.00 | 532.00K |
| Depreciation & Amortization | 3.15M | 7.10M | 2.40M | 1.95M | 792.00K | 7.00K | 98.00K | 7.00K |
| EBITDA | -7.14M | -34.39M | -18.07M | -33.44M | -70.91M | 9.25M | -2.18M | -4.66M |
| EBITDA Ratio | -36.44% | -87.23% | -21.62% | -55.05% | -424.84% | 0.00% | -943.29% | 0.00% |
| Operating Income | -10.61M | -41.97M | -20.15M | -35.35M | -29.00M | 9.24M | -2.25M | -4.67M |
| Operating Income Ratio | -54.18% | -106.47% | -24.10% | -58.19% | -173.77% | 0.00% | -974.46% | 0.00% |
| Total Other Income/Expenses | 5.51M | -5.82M | -1.23M | -550.00K | -52.37M | -9.06M | -26.00K | -532.00K |
| Income Before Tax | -13.40M | -43.60M | -21.38M | -35.90M | -81.37M | 2.39M | -2.28M | -5.20M |
| Income Before Tax Ratio | -68.43% | -110.60% | -25.57% | -59.10% | -487.52% | 0.00% | -985.71% | 0.00% |
| Income Tax Expense | 322.00K | -327.00K | -318.00K | -39.00K | -24.00K | -347.00K | -26.00K | -67.00K |
| Net Income | -13.40M | -43.27M | -21.38M | -35.90M | -81.34M | 2.73M | -2.28M | -5.13M |
| Net Income Ratio | -68.43% | -109.77% | -25.57% | -59.10% | -487.38% | 0.00% | -985.71% | 0.00% |
| EPS | -89.00 | -289.02 | -151.75 | -316.28 | -926.74 | 33.21 | -44.28 | -3.67 |
| EPS Diluted | -89.00 | -289.02 | -151.75 | -316.28 | -926.74 | 33.21 | -44.28 | -3.67 |
| Weighted Avg Shares Out | 150.61K | 149.72K | 140.88K | 113.51K | 87.77K | 82.27K | 51.42K | 1.40M |
| Weighted Avg Shares Out (Dil) | 150.61K | 149.72K | 140.88K | 113.51K | 87.77K | 82.27K | 51.42K | 1.40M |
Source: https://incomestatements.info
Category: Stock Reports